Home › Funds › D. E. Shaw & Co › SGMO
D. E. Shaw & Co position in SGMO
SANGAMO THERAPEUTICS INC
Latest position (Q2 2024)1.17M sh
Reported value held$417.78K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 41.91K | $378.00K | New |
| Q4 2021 | 554.75K | $4.16M | Add |
| Q1 2022 | 754.77K | $4.38M | Add |
| Q2 2022 | 1.16M | $4.79M | Add |
| Q3 2022 | 1.20M | $5.90M | Add |
| Q4 2022 | 1.38M | $4.32M | Add |
| Q1 2023 | 1.79M | $3.16M | Add |
| Q2 2023 | 2.38M | $3.10M | Add |
| Q3 2023 | 2.51M | $1.50M | Add |
| Q4 2023 | 4.68M | $2.54M | Add |
| Q1 2024 | 3.07M | $2.06M | Reduce |
| Q2 2024 | 1.17M | $417.78K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.